BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9603159)

  • 1. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses.
    He XY; Chen J; Verma N; Plain K; Tran G; Hall BM
    Transplantation; 1998 May; 65(9):1145-52. PubMed ID: 9603159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide production.
    Verma ND; Boyd R; Robinson C; Plain KM; Tran GT; Hall BM
    Transplantation; 2006 Nov; 82(10):1324-33. PubMed ID: 17130782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation.
    Davidson C; Verma ND; Robinson CM; Plain KM; Tran GT; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2007 Apr; 17(3):178-86. PubMed ID: 17331844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of TH2 cytokines.
    Plain KM; Fava L; Spinelli A; He XY; Chen J; Boyd R; Davidson CL; Hall BM
    Transplantation; 1997 Dec; 64(11):1559-67. PubMed ID: 9415556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
    J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
    Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
    Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW; Wasowska B; Papp I; Schmidbauer G; Sayegh MH; Baldwin WM; Wieder KJ; Hancock WW
    J Immunol; 1993 Nov; 151(9):5053-61. PubMed ID: 8409456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cellular basis of cardiac allograft rejection: VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient rats.
    Merten S; Chen JC; Ha H; Plain K; Boyd RA; Penny MJ; Leenaerts P; Hall BM
    Transplantation; 1998 May; 65(9):1152-8. PubMed ID: 9603160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.
    Chen X; Zhao S; Tang X; Ge H; Liu P
    Mol Vis; 2011; 17():2148-56. PubMed ID: 21850190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular basis of allograft rejection in vivo. V. Examination of the mechanisms responsible for the differing efficacy of monoclonal antibody to CD4+ T cell subsets in low- and high-responder rat strains.
    Ilano AL; McConnell MV; Gurley KE; Spinelli A; Pearce NW; Hall BM
    J Immunol; 1989 Nov; 143(9):2828-36. PubMed ID: 2572644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts.
    Jaques BC; Ahmiedat H; Alastair Gracie J; Marshall HE; Middleton SE; Bolton EM; Bradley JA
    Transplantation; 1998 Nov; 66(10):1291-9. PubMed ID: 9846511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.
    Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD
    Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action.
    Hall BM; Pearce NW; Gurley KE; Dorsch SE
    J Exp Med; 1990 Jan; 171(1):141-57. PubMed ID: 2136906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
    Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
    Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine interleukin 4 transgenic heart allograft survival prolonged with down-regulation of the Th1 cytokine mRNA in grafts.
    Takeuchi T; Ueki T; Sunaga S; Ikuta K; Sasaki Y; Li B; Moriyama N; Miyazaki J; Kawabe K
    Transplantation; 1997 Jul; 64(1):152-7. PubMed ID: 9233716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy.
    Plain KM; Chen J; Merten S; He XY; Hall BM
    Transplantation; 1999 Feb; 67(4):605-13. PubMed ID: 10071035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.